Skip to content
Business Segments · Depreciation

Diabetes — Depreciation

Medtronic Diabetes — Depreciation decreased by 89.6% to $32M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 88.1%, from $268M to $32M.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2025Feb 24, 2026
Rolls up toD&A

How to read this metric

An increase often reflects higher capital investment in production capacity, while a decrease may suggest aging infrastructure.

Detailed definition

This represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and facilities...

Peer comparison

Standard depreciation expense reported by manufacturing-heavy business segments.

Metric ID: mdt_segment_diabetes_depreciation

Historical Data

22 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25Q4 '25Q4 '25
Value$16.75M$16.75M$16.75M$16.75M$20M$20M$20M$20M$13M$248M$24M$262M$27M$268M$30M$17M$289M$31M$282M$32M$308M$32M
QoQ Change+0.0%+0.0%+0.0%+19.4%+0.0%+0.0%+0.0%-35.0%>999%-90.3%+991.7%-89.7%+892.6%-88.8%-43.3%>999%-89.3%+809.7%-88.7%+862.5%-89.6%
YoY Change+19.4%+19.4%+19.4%+19.4%-35.0%>999%+20.0%>999%+35.0%>999%+50.0%+30.8%+16.5%-87.5%+7.6%-87.8%+14.9%-88.1%
Range$13M$308M
CAGR+13.1%
Avg YoY Growth+196.9%
Median YoY Growth+19.4%

Frequently Asked Questions

What is Medtronic's diabetes — depreciation?
Medtronic (MDT) reported diabetes — depreciation of $32M in Q4 2025.
How has Medtronic's diabetes — depreciation changed year-over-year?
Medtronic's diabetes — depreciation decreased by 88.1% year-over-year, from $268M to $32M.
What does diabetes — depreciation mean?
The non-cash expense representing the wear and tear of equipment used to make diabetes products.